Therefore, our results suggest that BOP1 is an important regulator of CRC cell invasion and migration, predominantly through the JNK signaling pathway, and raise the possibility of using this molecule as an indicator for CRC treatment. The gene discussed is BOP1; the disease is colorectal carcinoma.